Oberursel, Germany

Gisbert Schneider

This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2005-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gisbert Schneider. Retrieved from https://idiyas.com/inventor/gisbert-schneider-7gqty7fo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2005-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Work of Inventor Gisbert Schneider

Introduction:

In the realm of pharmaceutical inventions, inventor Gisbert Schneider stands out for his valuable contributions to the field. Hailing from Oberursel, DE, Schneider has made a mark with his groundbreaking patents and commitment to advancing healthcare.

Latest Patents:

Schneider's latest patents revolve around Benzodioxole derivatives, offering a new avenue for the treatment and prevention of conditions like obesity. These compounds, formulated with precision and expertise, target CB1 receptors, showcasing Schneider's dedication to developing innovative solutions for challenging diseases.

Career Highlights:

With a total of 2 patents to his name, Gisbert Schneider has demonstrated a keen understanding of pharmacology and biochemistry. His work at Hoffmann-La Roche Inc. has been instrumental in pushing the boundaries of pharmaceutical research, paving the way for novel therapeutic interventions.

Collaborations:

Throughout his career, Schneider has collaborated closely with esteemed colleagues, one of whom is Alexander Alanine. Together, they have synergized their expertise to drive forward research projects and bring cutting-edge pharmaceutical innovations to fruition.

Conclusion:

In conclusion, Gisbert Schneider's inventive spirit and unwavering dedication to scientific excellence shine through in his remarkable patent portfolio. His contributions to the field of pharmacology are invaluable, shaping the landscape of healthcare for the better. Schneider's legacy as an inventor continues to inspire future generations to push the boundaries of innovation and discovery in the pursuit of better health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…